Eric Easom - Net Worth and Insider Trading

Eric Easom Net Worth

The estimated net worth of Eric Easom is at least $3 Million dollars as of 2024-06-21. Eric Easom is the CEO of AN2 Therapeutics Inc and owns about 1,212,012 shares of AN2 Therapeutics Inc (ANTX) stock worth over $3 Million. Details can be seen in Eric Easom's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric Easom has not made any transactions after 2024-01-02 and currently still holds the listed stock(s).

Transaction Summary of Eric Easom

To

Eric Easom Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Easom owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .

Click here to see the complete history of Eric Easom’s form 4 insider trades.

Insider Ownership Summary of Eric Easom

Ticker Comapny Transaction Date Type of Owner
ANTX AN2 Therapeutics Inc 2024-01-02 director & Chief Executive Officer

Eric Easom Latest Holdings Summary

Eric Easom currently owns a total of 1 stock. Eric Easom owns 1,212,012 shares of AN2 Therapeutics Inc (ANTX) as of January 2, 2024, with a value of $3 Million.

Latest Holdings of Eric Easom

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANTX AN2 Therapeutics Inc 2024-01-02 1,212,012 2.07 2,508,865

Holding Weightings of Eric Easom


Eric Easom Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Easom has made a total of 9 transactions in AN2 Therapeutics Inc (ANTX) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in AN2 Therapeutics Inc is the sale of 2,777 shares on January 2, 2024, which brought Eric Easom around $55,790.

Insider Trading History of Eric Easom

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Easom Trading Performance

GuruFocus tracks the stock performance after each of Eric Easom's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Easom is 58.53%. GuruFocus also compares Eric Easom's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Easom within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Easom's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Easom

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 33.94 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 26.94 LIMIT LIMIT LIMIT LIMIT LIMIT

Eric Easom Ownership Network

Ownership Network List of Eric Easom

No Data

Ownership Network Relation of Eric Easom

Insider Network Chart

Eric Easom Owned Company Details

What does AN2 Therapeutics Inc do?

Who are the key executives at AN2 Therapeutics Inc?

Eric Easom is the director & Chief Executive Officer of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include 10 percent owner Adjuvant Global Health Technology Fund De, L.p. , Chief Strategy Officer Kevin Michael Krause , and 10 percent owner Ra Capital Healthcare Fund Lp .

AN2 Therapeutics Inc (ANTX) Insider Trades Summary

Over the past 18 months, Eric Easom made 2 insider transaction in AN2 Therapeutics Inc (ANTX) with a net purchase of 7,223. Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , a net sale of 223,880 shares made by Kabeer Aziz , and a net sale of 10,000 shares made by Kevin Michael Krause .

In summary, during the past 3 months, insiders sold 0 shares of AN2 Therapeutics Inc (ANTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 565,631 shares of AN2 Therapeutics Inc (ANTX) were sold and 1,787,778 shares were bought by its insiders, resulting in a net purchase of 1,222,147 shares.

AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AN2 Therapeutics Inc Insider Transactions

No Available Data

Eric Easom Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Easom. You might contact Eric Easom via mailing address: 171 Forest Ln., Menlo Park Ca 94025.

Discussions on Eric Easom

No discussions yet.